About Brian Edlow, MD

Dr. Edlow received his B.A. from Princeton University and M.D. from the University of Pennsylvania School of Medicine. He completed an internal medicine internship at Brigham and Women's Hospital, followed by a neurology residency, NIH-funded neuroimaging fellowship, and neurocritical care fellowship at Massachusetts General Hospital and Brigham and Women's Hospital.

Dr. Edlow is currently a critical care neurologist at Massachusetts General Hospital, Vice Chair of Research at Mass General Brigham Neurology, and Associate Professor of Neurology at Harvard Medical School. He is the founding Director of the MGH Emerging Consciousness Program and Associate Director of the Center for Neurotechnology and Neurorecovery. 

Departments, Centers, & Programs:

Clinical Interests:

Treats:

Locations

Mass General Neurology: Neuroscience Intensive Care Unit
55 Fruit St.
Lunder Building
6th Floor
Boston, MA 02114
Phone: 857-238-5600

Mass General Vascular Center: Stroke Service
55 Fruit St.
Wang Ambulatory Care Center
7th Floor, Suite 720
Boston, MA 02114
Phone: 617-726-8459

Medical Education

  • MD, Perelman School of Medicine at the University of Pennsylvania***NSCH
  • Residency, Massachusetts General Hospital
  • Fellowship, Massachusetts General Hospital

American Board Certifications

  • Neurocritical Care, United Council for Neurologic Subspecialties
  • Neurology, American Board of Psychiatry & Neurology

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research

Dr. Edlow's research focuses on the development of advanced neurotechnologies to detect, predict and promote recovery from traumatic brain injury (Click Here). His lab's work has been continuously funded since 2010 by grants from the NIH, DOD, and multiple foundations. He is the recipient of the 2019 NIH Director's New Innovator Award, the 2022 American Neurological Association's Derek Denny-Brown Young Neurological Scholar Award, the 2023 Chen Institute MGH Research Scholar Award, and the 2024 Navy SEAL Foundation Scientific Achievement Award. Dr. Edlow serves on the Scientific Advisory Board of the Neurocritical Care Society's Curing Coma Campaign, the Editorial Board of the Journal of Neurotrauma, the NINDS Common Data Elements Project for Traumatic Brain Injury, the NINDS Board of Scientific Counselors, and as Chair of a Traumatic Brain Injury Study Section for the Department of Defense Congressionally Directed Medical Research Programs. He is also the Principal Investigator of the DOD-funded ReBlast study, which aims to develop a diagnostic test for brain injury from repeated blast exposure in United States Special Operations Forces. The goal of this work is to enhance the combat readiness, career longevity, and quality of life of the Special Operations Forces community.

Publications

Reviews: Comments and Ratings